article thumbnail

Patients Are Reaping the Benefits of Switching From Pharmaceuticals to MMJ

Veriheal

With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. What Is the Pharmaceutical Industry? pharmaceuticals).

article thumbnail

How does cannabis interact with pharmaceutical drugs?

Cannabis Life Network

Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis.

article thumbnail

More Women Switch Out Pharmaceuticals For Medical Marijuana

The Fresh Toast

More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women

article thumbnail

Celadon Pharmaceuticals Shares Rise After UK Quality Standard Registration

Cannabis Law Report

Celadon Pharmaceuticals PLC shares rose on Monday after the company said that its Midlands facility has been registered for the good manufacturing practice standard by the U.K.’s The UK-based pharmaceutical company focused on […].

article thumbnail

Portuguese Meducal Cannabis Company VF1883 Pharmaceuticals Declared Insolvent

Cannabis Law Report

VF1883 Pharmaceuticals, a medical cannabis producer based in Benavente, has been declared insolvent by the Santarém Court.

article thumbnail

Consumers Are Replacing Pharmaceuticals With Medical Marijuana

The Fresh Toast

Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. The post Consumers Are Replacing Pharmaceuticals With Medical Marijuana appeared first on The Fresh Toast. Cannabis Medical Marijuana News opioids pharmaceuticals

article thumbnail

Ibere Pharmaceuticals Is The Quiet SPAC

Cannabis Law Report

While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report.

article thumbnail

Corbus Pharmaceuticals Beats Estimates For Fourth Quarter

Cannabis Law Report

Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.…

article thumbnail

Global Cannabis Pharmaceuticals Market Research Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

The Global Cannabis Pharmaceuticals Market size was estimated at USD 872.57 Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others. Botanix Pharmaceuticals. Corbus Pharmaceuticals Holdings, Inc.

article thumbnail

Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™

Medical Marijuana Program Connection

–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. Read More. Business

article thumbnail

MyMD Pharmaceuticals Schedules Business Update Conference Call

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More. Business Wire

article thumbnail

Flora Growth to Acquire Pharmaceutical, Medical Cannabis Distributor in Germany

Cannabis Law Report

The transformative deal is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution.

article thumbnail

Global Cannabis Pharmaceuticals Market (2022 to 2027) – Featuring AbbVie, Amyris, Aurora Cannabis and Botanix Pharmaceuticals Among Others – ResearchAndMarkets.com

Cannabis Law Report

The Cannabis Pharmaceuticals Market is estimated to be USD 1.2

article thumbnail

Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership

Cannabis Law Report

Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.

article thumbnail

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products. The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space.

article thumbnail

Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™

Cannabis Law Report

–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS

article thumbnail

Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition

Cannabis Law Report

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The post Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition appeared first on Green Market Report.

article thumbnail

Virpax Pharmaceuticals Reports 2021 Year-End Results

Cannabis Law Report

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. –Company Advances All Pre-Clinical Programs– BERWYN, Pa.–(BUSINESS

article thumbnail

Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.

article thumbnail

Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.

article thumbnail

Marinus Pharmaceuticals Announces Presentations and Investor Event at American Epilepsy Society 2022 Annual Meeting

Cannabis Law Report

–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. RADNOR, Pa.–(BUSINESS

article thumbnail

Innovative Cannabis Brand Escape Artists Expands Into Michigan, Debuts Pharmaceutical-Grade Topicals

Medical Marijuana Program Connection

KALKASKA, Mich.–(BUSINESS –(BUSINESS WIRE)–Colorado-based cannabis brand Escape Artists, a top-selling maker of infused topicals for pain relief and recovery, today announced. Read More Business

article thumbnail

GW Pharmaceuticals loses $8 million over last quarter

Cannabis Law Report

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.

article thumbnail

United States Cannabis Pharmaceuticals Market Research Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

The United States Cannabis Pharmaceuticals Market size was estimated at USD 168.41 Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cannabis Pharmaceuticals Market, including.

article thumbnail

Cannabis vs. Pharmaceutical Medicine: One Not Very Surprising Study

Cannabis Law Report

Users are looking for safer alternatives to opioids, antidepressants, and arthritis relief. Green Entrepreneur

article thumbnail

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility

Cannabis Law Report

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East.

article thumbnail

Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)

Cannabis Law Report

–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. –VRPX Intranasal Cannabidiol Product Candidate for Management of Epilepsy in Children and Adults– BERWYN, Pa.–(BUSINESS

article thumbnail

Second Edition Pharmaceutical Cannabis Report 2021: Featuring Almirall, Bayer and Novartis Among Others – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. GW Pharmaceuticals.

article thumbnail

A2W Pharma Ltd Announces New Pharmaceutical Facility in Malta

Cannabis Law Report

MARSA, Malta–(BUSINESS WIRE)–A2W Pharma Ltd, a pharmaceutical company based in Malta, celebrates the opening of its new facility during a launch event on its premises today.

article thumbnail

 Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments

Cannabis Law Report

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. –Company Advances Product Candidate Pipeline—.

article thumbnail

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. in pharmaceutical sciences from the University of Kentucky and postdoctoral training in Biochemistry at the University of California, Berkeley. About Anebulo Pharmaceuticals, Inc.

article thumbnail

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug DMT Clinical Research Program for Stroke

Cannabis Law Report

Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.

article thumbnail

Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board

Cannabis Law Report

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.

article thumbnail

February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion

Cannabis Law Report

The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV

article thumbnail

MyMD Pharmaceuticals Set to Join Russell Microcap® Index

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. About MyMD Pharmaceuticals, Inc.

article thumbnail

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Cannabis Law Report

Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire